2022
DOI: 10.1055/s-0042-1745787
|View full text |Cite
|
Sign up to set email alerts
|

Interventional Palliation of Painful Extraspinal Musculoskeletal Metastases

Abstract: The musculoskeletal system is commonly involved by metastases, and skeletal-related events such as intractable pain due to direct osseous tumor involvement, pathologic fracture, and neurologic deficits as a result of nerve compression often adversely affect patient's quality of life. There have been substantial advances in percutaneous minimally invasive musculoskeletal oncologic interventions for the management of patients with musculoskeletal metastases including thermal ablations, cementation with or withou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 70 publications
0
1
0
Order By: Relevance
“…Skeletal-related adverse events (SREs), including pathological fractures, pain, and hypercalcemia, are frequent complications in metastatic bone cancer [ 23 25 ]. These complications substantially affect the patient’s quality of life [ 24 ] and can lead to severe outcomes, such as deep vein thrombosis, pneumonia, paraplegia, and even death [ 26 ]. As such, early identification, prevention, and management of SREs are critical in the treatment of metastatic bone cancer [ 6 , 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…Skeletal-related adverse events (SREs), including pathological fractures, pain, and hypercalcemia, are frequent complications in metastatic bone cancer [ 23 25 ]. These complications substantially affect the patient’s quality of life [ 24 ] and can lead to severe outcomes, such as deep vein thrombosis, pneumonia, paraplegia, and even death [ 26 ]. As such, early identification, prevention, and management of SREs are critical in the treatment of metastatic bone cancer [ 6 , 23 ].…”
Section: Discussionmentioning
confidence: 99%